Top Markets
Coin of the day
BioLineRx Ltd. BioLineRx Ltd.

BioLineRx Ltd.

BLRX
Rangering i aksjer #40526
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and... BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Aksjekurs
$0.0048574
Markedsverdi
$126.82K
Endring (1 dag)
0.00%
Endring (1 år)
-21.82%
Land
IL
Handel BioLineRx Ltd. (BLRX)

Kategori

Pris BLRX pris med markedsverdi på B
BioLineRx Ltd. BioLineRx Ltd.
BLRX
$0.0048574
Markedsverdi av BioLineRx Ltd.(BLRX)
Markedsverdi: $126.82K
Per August 2026 har BioLineRx Ltd. en markedsverdi på $126.82K. Dette gjør BioLineRx Ltd. til det 40526th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for BioLineRx Ltd. fra 2007 til 2026
BLRX sammenlignet med topp 5 mest populære stocks
Pris på BLRX Eiendel B Markedsverdi for B Resultater
BioLineRx Ltd. BioLineRx Ltd.
$209,495 $126.82K
$5.470T +4,312,917,893.90%
BioLineRx Ltd. BioLineRx Ltd.
$171,099 $126.82K
$4.467T +3,522,438,642.46%
BioLineRx Ltd. BioLineRx Ltd.
$159,888 $126.82K
$4.174T +3,291,646,617.50%
BioLineRx Ltd. BioLineRx Ltd.
$141,721 $126.82K
$3.700T +2,917,637,670.26%
BioLineRx Ltd. BioLineRx Ltd.
$109,328 $126.82K
$2.854T +2,250,746,944.65%